Omega-3 fatty acids are widely recognized for supporting heart health, brain function, and inflammation balance. But until the early 2000s, there was no reliable way to measure omega-3 levels in the body. That changed with the invention of the Omega-3 Index—a simple blood test that measures EPA and DHA levels in red blood cells and predicts long-term health outcomes.
This article is the first in a three-part series exploring the history, science, and future of the Omega-3 Index.
The Birth of the Omega-3 Index
The Omega-3 Index was co-invented by Dr. Bill Harris, a lipid researcher with over 40 years of experience, and Dr. Clemens von Schacky, a preventive cardiologist in Germany. Together, they recognized the need for a standardized test to measure omega-3 status and its relationship to cardiovascular risk.
Their inspiration came from two landmark studies:
-
1996 JAMA study (David Siscovick, et al.) – Researchers compared omega-3 blood levels in people who suffered sudden cardiac arrest against healthy controls. Results showed that individuals with the highest omega-3 levels were 90% less likely to experience sudden cardiac arrest.
-
2002 NEJM study (Christine Albert, et al.) – In this prospective study of 16,000 physicians, those with higher omega-3 blood levels at baseline were also 90% less likely to suffer cardiac events over the following 17 years.
These studies convinced Drs. Harris and von Schacky that omega-3 blood levels were not just diet markers, but independent risk factors for heart disease. In 2004, they formally proposed the Omega-3 Index as a new cardiovascular risk marker.
What Is the Omega-3 Index?
The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes, expressed as a share of total fatty acids.
-
Optimal range: 8–12%
-
Intermediate: 4–8%
-
High risk: Below 4%
Why red blood cells? Research in heart transplant patients confirmed that omega-3 levels in red cells strongly correlated with levels in heart tissue. This makes the Omega-3 Index a reliable proxy for tissue omega-3 status throughout the body.
Why the Omega-3 Index Matters
Unlike the debated Omega-6/Omega-3 ratio, the Omega-3 Index focuses specifically on EPA and DHA—the fatty acids most strongly linked to cardiovascular protection. Low levels of EPA and DHA are consistently associated with higher risks of sudden cardiac death, heart attacks, and chronic inflammation.
Countries like Japan and Korea, where Omega-3 Index levels average near 9–10%, have some of the lowest cardiovascular disease rates in the world. By contrast, average levels in the U.S., Canada, and Europe hover around 5%, well below the protective range.
Global Health Implications
Since its introduction, the Omega-3 Index has been cited in over 700 scientific papers and used in more than 200 published studies. The evidence clearly shows that:
-
A higher Omega-3 Index (8–12%) is linked with reduced risk of fatal coronary events.
-
Levels below 4% represent significantly higher risk.
-
Most Western populations fall short of the optimal range.
This makes the Omega-3 Index not just a laboratory measure, but a practical health marker—comparable to cholesterol or blood pressure testing.
Why This Test Is a Game-Changer
-
Predictive value: The Omega-3 Index reflects long-term omega-3 intake and predicts disease risk.
-
Actionable insights: If your levels are low, increasing EPA and DHA intake through fish or high-quality fish oil supplements can raise them into the protective range.
-
Personalized nutrition: The test helps tailor supplementation and diet to individual needs.
Looking Ahead
The Omega-3 Index has already changed how we understand fatty acids and disease prevention. As research expands, it may play an even larger role in personalized medicine, preventative cardiology, and global nutrition strategies.
For now, the message is clear: knowing your Omega-3 Index gives you a powerful tool for protecting your heart, brain, and overall health.